{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:40:01Z","timestamp":1748479201769,"version":"3.41.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99HL116769","R01HL056046"],"award-info":[{"award-number":["K99HL116769","R01HL056046"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13SDG16840035"],"award-info":[{"award-number":["13SDG16840035"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vph.2015.06.013","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T03:22:41Z","timestamp":1435893761000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice"],"prefix":"10.1016","volume":"76","author":[{"given":"Kathryn E.","family":"Husarek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige S.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron J.","family":"Trask","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten L.","family":"Galantowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary J.","family":"Cismowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A.","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.06.013_bb0005","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1523-1755.2002.00311.x","article-title":"Angiotensin II activation of the JAK\/STAT pathway in mesangial cells is altered by high glucose","volume":"61","author":"Amiri","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.vph.2015.06.013_bb0010","first-page":"S107","article-title":"Role of local and systemic angiotensin in diabetic renal disease","volume":"63","author":"Anderson","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.vph.2015.06.013_bb0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-2143(96)90142-0","article-title":"Diversity of phenotype and function of vascular smooth muscle cells","volume":"127","author":"Archer","year":"1996","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.vph.2015.06.013_bb0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.06.013_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1586\/14779072.6.1.127","article-title":"Diabetes and vascular disease","volume":"6","author":"Deedwania","year":"2008","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.vph.2015.06.013_bb0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.RES.0000200738.50997.f2","article-title":"Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenic stimuli","volume":"98","author":"Deng","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2015.06.013_bb0035","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1152\/physrev.00045.2006","article-title":"Regulation of coronary blood flow during exercise","volume":"88","author":"Duncker","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2015.06.013_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.0000112029.03691.e7","article-title":"Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment","volume":"43","author":"Endemann","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.06.013_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/physiolgenomics.00111.2010","article-title":"Vascular smooth muscle phenotypic diversity and function","volume":"42A","author":"Fisher","year":"2010","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.vph.2015.06.013_bb0050","first-page":"330","article-title":"Exercise is the real polypill","volume":"28","author":"Fiuza-Luces","year":"2013","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.vph.2015.06.013_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2008.12.049","article-title":"Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts","volume":"606","author":"Gao","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.06.013_bb0060","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/heart.89.10.1236","article-title":"Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart","volume":"89","author":"Hayashi","year":"2003","journal-title":"Heart"},{"issue":"215\u2013238","key":"10.1016\/j.vph.2015.06.013_bb0065","first-page":"xi","article-title":"Microvascular complications of diabetes","volume":"33","author":"He","year":"2004","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.vph.2015.06.013_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCRESAHA.107.148338","article-title":"Angiotensin-converting enzyme and vascular remodeling","volume":"101","author":"Heeneman","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2015.06.013_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1291\/hypres.31.615","article-title":"Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy","volume":"31","author":"Hinoi","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2015.06.013_bb0080","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/diacare.26.3.917","article-title":"Economic costs of diabetes in the US in 2002","volume":"26","author":"Hogan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2015.06.013_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Investigators, H.O.P.E.S.","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2015.06.013_bb0090","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2007-0393","article-title":"Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus","volume":"92","author":"Joffe","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2015.06.013_bb0095","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00395-011-0201-0","article-title":"Coronary arterioles in type 2 diabetic (db\/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness","volume":"106","author":"Katz","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2005.09.014","article-title":"Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist","volume":"151","author":"Kawata","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2015.06.013_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabres.2009.01.010","article-title":"Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients","volume":"84","author":"Kjaer","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.vph.2015.06.013_bb0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1463-1326.2007.00670.x","article-title":"Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications","volume":"9","author":"Krentz","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.vph.2015.06.013_bb0115","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","article-title":"Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes","volume":"46","author":"Laing","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.vph.2015.06.013_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1470320309347785","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Lemarie","year":"2010","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.vph.2015.06.013_bb0125","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2015.06.013_bb0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.17.5.382","article-title":"Muscle fiber composition and capillary density in women and men with NIDDM","volume":"17","author":"Marin","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2015.06.013_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1573399054022802","article-title":"Angiotensin II-induced signaling pathways in diabetes","volume":"1","author":"Marrero","year":"2005","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.vph.2015.06.013_bb0140","doi-asserted-by":"crossref","first-page":"24684","DOI":"10.1074\/jbc.272.39.24684","article-title":"Role of Janus kinase\/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation","volume":"272","author":"Marrero","year":"1997","journal-title":"J. Biol. Chem."},{"year":"2004","series-title":"Diabetes and Cardiovascular Disease: Integrating Science and Clinical Medicine","author":"Marso","key":"10.1016\/j.vph.2015.06.013_bb0145"},{"key":"10.1016\/j.vph.2015.06.013_bb0150","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.98.24.2765","article-title":"Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo","volume":"98","author":"McEwan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.013_bb0155","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0160","doi-asserted-by":"crossref","first-page":"H2167","DOI":"10.1152\/ajpheart.00403.2006","article-title":"Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression","volume":"292","author":"Methe","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.91.3.635","article-title":"Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus","volume":"91","author":"Nahser","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.013_bb0170","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1073\/pnas.232551499","article-title":"Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA","volume":"99","author":"Neese","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2015.06.013_bb0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/diab.42.7.1017","article-title":"Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function","volume":"42","author":"Nitenberg","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2015.06.013_bb0180","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1152\/ajprenal.00049.2007","article-title":"Compromised renal microvascular reactivity of angiotensin type 1 double null mice","volume":"293","author":"Park","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1582-4934.2012.01660.x","article-title":"What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes","volume":"17","author":"Ragni","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2015.06.013_bb0190","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","article-title":"Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan","volume":"101","author":"Schiffrin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.013_bb0195","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1161\/01.CIR.0000041432.80615.A5","article-title":"Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia","volume":"106","author":"Schofield","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.013_bb0200","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/S0895-7061(00)00274-0","article-title":"The role of the AT2 receptor in hypertension","volume":"13","author":"Siragy","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2015.06.013_bb0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","article-title":"Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells","volume":"52","author":"Touyz","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.vph.2015.06.013_bb0210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vph.2012.07.007","article-title":"Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training","volume":"57","author":"Trask","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2015.06.013_bb0215","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1152\/japplphysiol.00604.2012","article-title":"Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome","volume":"113","author":"Trask","year":"2012","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.vph.2015.06.013_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11906-000-0067-2","article-title":"Regulation of matrix proteins and impact on vascular structure","volume":"2","author":"Tunon","year":"2000","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.vph.2015.06.013_bb0225","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0735-1097(99)00331-9","article-title":"Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure: evidence of impaired reactivity to nitroglycerin","volume":"34","author":"Vavuranakis","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0230","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.clinthera.2007.09.019","article-title":"Effects of renin\u2013angiotensin system inhibition on end-organ protection: can we do better?","volume":"29","author":"Weir","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.vph.2015.06.013_bb0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11892-003-0012-2","article-title":"Growth factors and the development of diabetic nephropathy","volume":"3","author":"Wolf","year":"2003","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.vph.2015.06.013_bb0240","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1152\/ajpendo.00629.2010","article-title":"Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage","volume":"301","author":"Yang","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2015.06.013_bb0245","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0735-1097(97)00327-6","article-title":"Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus","volume":"30","author":"Yokoyama","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0250","doi-asserted-by":"crossref","first-page":"H2154","DOI":"10.1152\/ajpheart.00987.2004","article-title":"Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors","volume":"288","author":"Zhang","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2015.06.013_bb0255","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/ATVBAHA.110.214700","article-title":"Coronary and aortic endothelial function affected by feedback between adiponectin and tumor necrosis factor alpha in type 2 diabetic mice","volume":"30","author":"Zhang","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.06.013_bb0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1378\/chest.94.1.5","article-title":"Small-vessel disease, coronary artery vasodilator reserve, and diabetic cardiomyopathy","volume":"94","author":"Zoneraich","year":"1988","journal-title":"Chest"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:21:14Z","timestamp":1748478074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115001445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":52,"alternative-id":["S1537189115001445"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.06.013","relation":{},"ISSN":["1537-1891"],"issn-type":[{"type":"print","value":"1537-1891"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}